517
Views
18
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Risk stratification of diffuse large B-cell lymphoma with interim PET-CT based on different cutoff Deauville scores

, , , &
Pages 340-347 | Received 01 Mar 2017, Accepted 04 Jun 2017, Published online: 20 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Kristine Broglio, Lale Kostakoglu, Carol Ward, Federico Mattiello, Denis Sahin, Tina Nielsen, Anna McGlothlin, Corrine F. Elliott, Thomas Witzig, Laurie H. Sehn, Marek Trnĕný, Umberto Vitolo, Maurizio Martelli, Margaret Foster, Barbara Wendelberger, Grzegorz Nowakowski & Donald A. Berry. (2022) PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design. Leukemia & Lymphoma 63:12, pages 2816-2831.
Read now
Wei Xie, Meng-Ke Liu, Xu-Feng Jiang, Xiao-Dong Gao, Biao Li, Li Wang & Wei-Li Zhao. (2021) Improved prediction of chemoresistance in patients with diffuse large B-cell lymphoma through a new interim positron emission tomography-computed tomography evaluation model. Acta Oncologica 60:6, pages 735-743.
Read now
Long Qian, Miaoming Yan, Wei Zhang, Daobin Zhou, Yan Zhang, Li Huo, Yaping Luo, Yingqiang Zhang & Shaoxuan Hu. (2020) Prognostic value of interim 18F-FDG PET/CT in T-cell lymphomas. Leukemia & Lymphoma 61:4, pages 927-933.
Read now
Hongwei Sun, Zhan Yu, Ning Ma, Jie Zhou, Rongrong Tian, Ming Zhao & Tong Wang. (2019) Risk Stratification Of Diffuse Large B-Cell Lymphoma With Interim PET/CT By Combining Deauville Scores And International Prognostic Index. Cancer Management and Research 11, pages 9449-9457.
Read now

Articles from other publishers (14)

Na Dai, Rongcui Cai, Shengming Deng & Shibiao Sang. (2023) Analysis of Positive Results of 18F-FDG PET/CT Imaging after Hematopoietic Stem Cell Transplantation in Lymphoma. Diagnostics 13:12, pages 2027.
Crossref
Lucia Zanoni, Davide Bezzi, Cristina Nanni, Andrea Paccagnella, Arianna Farina, Alessandro Broccoli, Beatrice Casadei, Pier Luigi Zinzani & Stefano Fanti. (2023) PET/CT in Non-Hodgkin Lymphoma: An Update. Seminars in Nuclear Medicine 53:3, pages 320-351.
Crossref
Sujeet Kumar, Anshul Gupta, Manish Ora, Khaliqur Rahman, Sanjeev, Reena Choudhary & Soniya Nityanand. (2021) Prognostic Role of Interim 18-Fluorodeoxyglucose-PET in Diffuse Large B Cell Lymphoma: Experience from a Tertiary Care Centre in North India. Indian Journal of Hematology and Blood Transfusion 38:2, pages 211-222.
Crossref
Xue Shi, Xiaoqian Liu, Xiaomei Li, Yahan Li, Dongyue Lu, Xue Sun, Ying Li, Shunfeng Hu, Yuanfeng Zhang, Xiangxiang Zhou, Xin Wang, Haiping Chen & Xiaosheng Fang. (2021) Risk Stratification for Diffuse Large B-Cell Lymphoma by Integrating Interim Evaluation and International Prognostic Index: A Multicenter Retrospective Study. Frontiers in Oncology 11.
Crossref
Meral Uluköylü Mengüç, Özgür Mehtap, Gözde Dağlıöz Görür, Elif Birtaş Ateşoğlu, Ayfer Gedük, Serkan Ünal, Pınar Tarkun & Abdullah Hacıhanefioğlu. (2021) The Role of Interim PET/CT on Survival in Diffuse Large B Cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 21:11, pages e922-e927.
Crossref
Yi Wen Mo, Zi Zheng Xiao, Yuan Wei, Xin Ling Li, Xu Zhang & Wei Fan. (2021) The Clinical Accuracy and Risk Stratification in End of Therapy 18F-FDG PET/CT in Burkitt Lymphoma. Frontiers in Oncology 11.
Crossref
Sally F Barrington & Judith Trotman. (2021) The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma. The Lancet Haematology 8:1, pages e80-e93.
Crossref
Hye Park, Eun Han, Joo O, Byung-Ock Choi, Gyeongsin Park, Seung-Eun Jung, Seung-Ah Yahng, Ki-Seong Eom & Seok-Goo Cho. (2020) Early Interim Chemotherapy Response Evaluation by F-18 FDG PET/CT in Diffuse Large B Cell Lymphoma. Diagnostics 10:12, pages 1002.
Crossref
Sung Kyun Yim, Ho-Young Yhim, Yeon-Hee Han, So-Yeon Jeon, Na-Ri Lee, Eun-Kee Song, Hwan-Jeong Jeong, Hee Sun Kim & Jae-Yong Kwak. (2019) Early risk stratification for diffuse large B-cell lymphoma integrating interim Deauville score and International Prognostic Index. Annals of Hematology 98:12, pages 2739-2748.
Crossref
J.G. Peacock, C.T. Christensen & K.P. Banks. (2019) RESISTing the Need to Quantify: Putting Qualitative FDG-PET/CT Tumor Response Assessment Criteria into Daily Practice. American Journal of Neuroradiology.
Crossref
Renata Nyilas, Bence Farkas, Reka Rahel Bicsko, Ferenc Magyari, Laszlo Imre Pinczes, Arpad Illes & Lajos Gergely. (2019) Interim PET/CT in diffuse large B-cell lymphoma may facilitate identification of good-prognosis patients among IPI-stratified patients. International Journal of Hematology 110:3, pages 331-339.
Crossref
Ling Yuan, Michael C. Kreissl, Liping Su, Zhifang Wu, Marcus Hacker, Jianzhong Liu, Xi Zhang, Yunfeng Bo, Hongyu Zhang, Xiang Li & Sijin Li. (2018) Prognostic analysis of interim 18F-FDG PET/CT in patients with diffuse large B cell lymphoma after one cycle versus two cycles of chemotherapy. European Journal of Nuclear Medicine and Molecular Imaging 46:2, pages 478-488.
Crossref
Coreline N. Burggraaff, Antoinette de Jong, Otto S. Hoekstra, Nikie J. Hoetjes, Rutger A. J. Nievelstein, Elise P. Jansma, Martijn W. Heymans, Henrica C. W. de Vet & Josée M. Zijlstra. (2018) Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis. European Journal of Nuclear Medicine and Molecular Imaging 46:1, pages 65-79.
Crossref
Jeong Won Lee & Sang Mi Lee. (2017) Radiomics in Oncological PET/CT: Clinical Applications. Nuclear Medicine and Molecular Imaging 52:3, pages 170-189.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.